Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.sparc.life | |
Market Cap | 9,284.56 Cr. | |
Enterprise Value(EV) | 9,558.29 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -11.20 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.03 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 7.15 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 40.01 | Calculated using Price: 286.10 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 32.45 Cr. | 324,521,588 Shares |
FaceValue | 1 | |
About Sun Pharma Advanced Research Company Ltd. | ||
The company is engaged in the pharmaceutical research and development. The company's core focus is innovation and new product development for global markets. SPARC undertakes projects in research and technology for new chemical entities (NCE's) or new molecules, and novel drug delivery systems (NDDS). |
1 Day |
|
-5.00% |
1 Week |
|
-22.61% |
1 Month |
|
-24.32% |
3 Month |
|
-21.31% |
6 Month |
|
+28.27% |
1 Year |
|
+46.76% |
2 Year |
|
+3.56% |
5 Year |
|
+60.15% |
10 Year |
|
+85.28% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -33.17 | -109.16 | -127.4 | -156.84 | -74.72 | -225.08 | 0 | 0 | -143.72 | |
Return on Capital Employed (%) | -31.74 | -71.37 | -94.66 | -113.05 | -59.95 | -178.95 | -254.1 | -225.57 | -69.44 | |
Return on Assets (%) | -23.65 | -44.68 | -53.72 | -66.85 | -40.89 | -93.11 | -60.18 | -79.8 | -40.1 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 100 | 32 | 158 | 185 | 296 | -19 | -168 | 31 | 513 | 332 | |
Non Curr. Liab. | 10 | 10 | 10 | 12 | 7 | 56 | 165 | 77 | 138 | 123 | |
Curr. Liab. | 37 | 125 | 108 | 116 | 95 | 235 | 233 | 171 | 179 | 213 | |
Minority Int. | |||||||||||
Equity & Liab. | 147 | 167 | 277 | 313 | 398 | 273 | 230 | 280 | 830 | 667 | |
Non Curr. Assets | 83 | 99 | 118 | 138 | 141 | 205 | 167 | 209 | 375 | 225 | |
Curr. Assets | 63 | 67 | 158 | 175 | 257 | 67 | 60 | 71 | 455 | 443 | |
Misc. Exp. not W/O | 0 | 1 | |||||||||
Total Assets | 147 | 167 | 277 | 313 | 398 | 273 | 230 | 280 | 830 | 667 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 156 | 161 | 181 | 78 | 183 | 77 | 253 | 137 | 239 | 107 | |
Other Income | 3 | 3 | 14 | 5 | 14 | 10 | 5 | 7 | 11 | 36 | |
Total Income | 159 | 164 | 195 | 83 | 196 | 87 | 258 | 144 | 250 | 142 | |
Total Expenditure | -191 | -224 | -304 | -321 | -334 | -387 | -388 | -324 | -453 | -493 | |
PBIDT | -32 | -60 | -109 | -238 | -138 | -300 | -130 | -180 | -203 | -350 | |
Interest | 0 | -2 | -2 | 0 | 0 | -3 | -11 | -13 | -8 | -1 | |
Depreciation | -7 | -8 | -8 | -8 | -8 | -9 | -11 | -10 | -12 | -12 | |
Taxation | |||||||||||
Exceptional Items | 49 | ||||||||||
PAT | -40 | -70 | -119 | -197 | -145 | -312 | -151 | -203 | -223 | -363 | |
Adjusted EPS | -2 | -3 | -5 | -8 | -6 | -12 | -6 | -7 | -7 | -11 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 37 | -41 | -44 | -128 | -183 | -172 | -211 | -152 | -208 | -69 | |
Cash Fr. Inv. | 44 | 53 | -13 | -7 | -105 | -102 | 155 | 2 | -29 | -548 | |
Cash Fr. Finan. | -81 | -1 | 51 | 194 | 224 | 274 | 55 | 159 | 229 | 617 | |
Net Change | 0 | 11 | -7 | 60 | -63 | 0 | 9 | -8 | -1 | ||
Cash & Cash Eqvt | 0 | 11 | 4 | 64 | 0 | 0 | 0 | 9 | 1 | 1 |
Thu, 18 Apr 2024
Analysts/Institutional Investor Meet/Con. Call Updates Sun Pharma Advanced Research Company Limited has informed the Exchange about Transcript |
Wed, 17 Apr 2024
Analysts/Institutional Investor Meet/Con. Call Updates Sun Pharma Advanced Research Company Limited has informed the Exchange about Link of Recording |
Wed, 10 Apr 2024
Press Release Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated April 10, 2024, titled Corporate Announcement. |
Tue, 23 Apr 2024 |
High Delivery Percentage |
Higher Delivery Quantity |
Higher Delivery Quantity and Percentage |
Higher Trade Quantity |
Higher Trade and Delivery Quantity |